Brokers Set Expectations for Clorox’s Q4 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Research analysts at Zacks Research increased their Q4 2025 earnings estimates for shares of Clorox in a research note issued to investors on Monday, May 19th. Zacks Research analyst R. Department now expects that the company will earn $2.23 per share for the quarter, up from their previous forecast of $2.14. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q1 2026 earnings at $1.52 EPS, Q2 2026 earnings at $1.51 EPS, Q3 2026 earnings at $1.57 EPS, FY2026 earnings at $6.71 EPS, Q1 2027 earnings at $1.62 EPS, Q2 2027 earnings at $1.71 EPS and Q3 2027 earnings at $1.70 EPS.

CLX has been the topic of several other reports. Wells Fargo & Company dropped their price objective on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Morgan Stanley dropped their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 6th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. lowered their price target on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 6th. Finally, Citigroup lowered their price target on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, April 14th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $151.23.

Clorox Stock Performance

Shares of CLX opened at $131.90 on Wednesday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market capitalization of $16.26 billion, a P/E ratio of 36.04, a P/E/G ratio of 2.62 and a beta of 0.60. The company’s fifty day moving average is $140.26 and its two-hundred day moving average is $152.82. Clorox has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. Clorox had a net margin of 6.38% and a return on equity of 316.87%. The business’s quarterly revenue was down 8.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.71 earnings per share.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CLX. Brooklyn Investment Group lifted its holdings in Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC purchased a new position in Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC purchased a new position in Clorox in the 4th quarter valued at about $31,000. Wood Tarver Financial Group LLC purchased a new position in Clorox in the 4th quarter valued at about $31,000. Finally, Asset Planning Inc purchased a new position in shares of Clorox during the 4th quarter worth about $32,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 4,000 shares of Clorox stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.57% of the company’s stock.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 9th. Investors of record on Wednesday, April 23rd were given a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.70%. Clorox’s dividend payout ratio is presently 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.